Coave Therapeutics
FranceEntry
2017
Hold
9yr
Status
Active
Who owns Coave Therapeutics?
Coave Therapeutics is a French Biotech company, currently owned by Novo Holdings since 2021 and 2 other investors.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2015 · present
Turenne GroupeActive
2015 · present(11yr) · Capital Santé 2 · 2020 · Growth
Go CapitalActive
2017 · present(9yr) · GO Capital · 2021 · VC
Novo HoldingsActive
2021 · present(5yr) · Novo Holdings Venture Investments · 1999 · VC
More from GO Capital
Other portfolio companies in the same fund.
More Go Capital portfolio companies
From the same investor, across funds.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Coave Therapeutics?
Coave Therapeutics is currently owned by Novo Holdings, Go Capital and 1 other, through GO Capital, since 2021.
When did Novo Holdings and 2 others acquire Coave Therapeutics?
Novo Holdings and 2 others acquired Coave Therapeutics in 2021.
Who has owned Coave Therapeutics over time?
Coave Therapeutics has been through 3 private-equity ownership periods: Turenne Groupe · via Capital Santé 2 · since 2015; Go Capital · via GO Capital · since 2017; Novo Holdings · via Novo Holdings Venture Investments · since 2021.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue